Adona Medical
Adona Medical is a pre-commercial medical device company developing an adjustable interatrial shunt with integrated pressure monitoring and a remote monitoring solution to personalize treatment for heart failure patients, serving hospitals and cardiac care centers.
- Company typePrivate
- Founded2017
- HeadquartersLos Gatos, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Adona Medical does
Adona Medical is a pre-commercial medical device company founded in 2017 and headquartered in Los Gatos, California, that is developing an adjustable interatrial shunt with integrated pressure monitoring for the treatment of heart failure. The company targets the approximately 6.5 million heart failure patients in the United States and 26 million globally, with particular relevance to those with preserved or mildly reduced ejection fraction who have limited therapeutic options. Adona operates as a portfolio company of Shifamed and has raised roughly $95.5 million across disclosed funding rounds between 2019 and 2024, with Cormorant Asset Management serving as lead or co-lead investor in every major round.
The core technology is an implantable interatrial shunt device that creates a controlled passage between the left and right atria, with adjustable flow capability intended to personalize therapy to individual patient hemodynamics. Integrated pressure sensors embedded in the device enable continuous hemodynamic monitoring, and a companion remote monitoring solution transmits patient data outside of clinical settings so clinicians can titrate shunt settings over time. Together, the mechanical shunt, embedded sensors, and remote monitor constitute an integrated heart failure management platform rather than a single standalone product.
Adona is currently in clinical development and has not yet commercialized. The intended revenue model is hardware sales of the device to hospitals and cardiac care centers, with enterprise field sales targeting interventional cardiologists, hospital procurement, and reimbursement stakeholders typical of medtech. The company has 11–50 employees, has not publicly disclosed pricing, and has not yet recorded commercial revenue; near-term value creation is contingent on completing clinical trials and securing regulatory clearance.
Adona Medical firmographics
Firmographics- Name
- Adona Medical
- Legal name
- Adona Medical
- Website
- https://adonamed.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Adona Medical is a pre-commercial medical device company developing an adjustable interatrial shunt with integrated pressure monitoring and a remote monitoring solution to personalize treatment for heart failure patients, serving hospitals and cardiac care centers.
- Ownership category
- akta.pro rank
Adona Medical industry classification
Industry- Product category
- Interventional Cardiology Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)
- akta.pro secondary industries
- Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)
Keywords
Where Adona Medical is headquartered
LocationHeadquarters
- HQ city
- Los Gatos
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Adona Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Adona Medical is developing an implantable medical device (interatrial shunt) for heart failure treatment. Revenue will be generated through the sale of devices to hospitals and cardiac care centers, combined with associated procedural revenue from implantation procedures. As a pre-commercial stage company currently in clinical trials, the revenue model is not yet operational.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Adona Medical product offering
Product offeringCore offering
Adona Medical develops an adjustable interatrial shunt device with integrated pressure monitoring sensors designed to treat heart failure patients by creating a controlled passage between the left and right atria of the heart. The device enables personalized treatment through adjustable flow settings and continuous hemodynamic monitoring, supported by a companion remote monitoring system that allows healthcare providers to track patient data outside of clinical settings. The product is currently in clinical development and not yet commercially available.
Product overview
Adona Medical offers a unified heart failure management platform centered on its adjustable interatrial shunt device with integrated pressure monitoring. The platform includes a companion remote monitoring solution that enables clinicians to track patient data and pressure readings. The core product features adjustable flow control to allow personalized treatment tailored to individual heart failure patients.
Differentiator
Problem solved
Functional benefit
Products and services
- Adjustable Interatrial Shunt An implantable medical device designed to treat heart failure patients by creating a shunt between the atria of the heart, featuring adjustable flow control to allow personalized treatment based on individual patient needs.
- Remote Monitoring Solution A companion monitoring system integrated with the interatrial shunt device that enables remote tracking of patient data and pressure readings, supporting ongoing heart failure management by healthcare providers.
- Heart Failure Management Platform A comprehensive technology platform for heart failure treatment that combines the adjustable interatrial shunt device with integrated pressure sensors and remote monitoring capabilities to enable personalized treatment for heart failure patients.
Companies that use Adona Medical
Customer profileSegments1 record
Ideal customer profiles1 record
Adona Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Adona Medical partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Adona Medical competitors and assessment
Company assessmentDirect peers
- V-Wave: Developer of the Ventura interatrial shunt for heart failure with reduced and preserved ejection fraction. Competes head-to-head with Adona in the interatrial shunt category and is further along clinically (RELIEVE-HF trial).
- Corvia Medical: Direct competitor developing an interatrial shunt device (IASD) for heart failure, with the most advanced clinical program (REDUCE LAP-HF) in the same category as Adona's adjustable shunt. Most comparable peer by indication, mechanism, and target population.
Broad incumbents
- Abbott: Large diversified medtech with structural heart, heart failure, and remote monitoring businesses (including CardioMEMS). Comparable in targeting heart failure with device + monitoring and is a logical acquirer of shunt assets.
- Medtronic: Broad cardiovascular incumbent spanning structural heart, heart failure diagnostics, and remote monitoring. Operates in adjacent heart failure device categories and represents potential strategic acquirer of Adona.
- Edwards Lifesciences: Global structural heart incumbent with a large heart failure and transcatheter valve portfolio. While not focused exclusively on interatrial shunting, it is the most likely strategic acquirer of assets like Adona and sets the bar on commercial scale.
- Boston Scientific: Major structural heart and electrophysiology incumbent with growing heart failure device ambitions (e.g., acquisitions in atrial shunt space). Comparable as a broad cardiac device incumbent pursuing HFpEF solutions.
Emerging players
- Alleviant Medical: Developer of a no-implant interatrial shunt approach using a catheter-based procedure to create a shunt that later heals open. Targets the same HFpEF patient population as Adona with an alternative, less invasive mechanism.
- Vectorious Medical Technologies: Developer of an implantable left atrial pressure sensor (V-LAP) for heart failure monitoring, conceptually similar to Adona's integrated pressure sensing component. Comparable on the remote hemodynamic monitoring dimension of the platform.
- Occlutech: European-based developer of atrial flow regulators and interatrial shunt devices (AFR) for heart failure. Direct technology overlap with Adona's mechanism and serves as a regional/emerging alternative in the same therapeutic category.
- Procyrion: Developer of the Aortix percutaneous mechanical circulatory support device for heart failure. While a different mechanism, it addresses the same advanced heart failure population and represents another interventional HF device peer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Adona Medical social profiles
Digital presenceAdona Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Adona Medical leadership team
Management profileNumber of profiles
Profiles1 record
Adona Medical funding detail
Funding detailFunding overview
Funding rounds4 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Adona Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Adona Medical
What does Adona Medical do?
Adona Medical develops an adjustable interatrial shunt device with integrated pressure monitoring sensors designed to treat heart failure patients by creating a controlled passage between the left and right atria of the heart. The device enables personalized treatment through adjustable flow settings and continuous hemodynamic monitoring, supported by a companion remote monitoring system that allows healthcare providers to track patient data outside of clinical settings. The product is currently in clinical development and not yet commercially available.
Is Adona Medical a public or private company?
Adona Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Adona Medical founded?
Adona Medical was founded in 2017. It employs 11 to 50 people.
Where is Adona Medical based?
Adona Medical is headquartered in Los Gatos, United States, in the North America region.
How does Adona Medical make money?
One revenue line is on record: medical Device Sales.
Who are Adona Medical's main competitors?
Direct peers on record are V-Wave and Corvia Medical. Broad incumbents are Abbott, Medtronic, Edwards Lifesciences and Boston Scientific. Emerging players are Alleviant Medical, Vectorious Medical Technologies, Occlutech and Procyrion.
Does Adona Medical have an API?
No public API is recorded for Adona Medical.
What industry is Adona Medical in?
Adona Medical's product category is Interventional Cardiology Medical Devices. Its primary akta.pro industry code is HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation), with a secondary code of HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT). Its NAICS code is 334510 and its SIC code is 3841.